Exploring the Impact of Natural Language Processing in Clinical Trials, Regulatory, Healthcare Efficiency, and Drug Discovery Processes

Abstract

Natural Language Processing (NLP) has emerged as a transformative technology in pharmaceutical research and drug development, offering significant potential to enhance efficiency, reduce costs, and accelerate timelines. This paper explores the application of NLP in the pharmaceutical industry, focusing on its current trends, emerging technologies, and future directions. NLP techniques, including text mining, sentiment analysis, and information extraction, are increasingly being used to analyze vast amounts of unstructured data from clinical trial reports, scientific literature, regulatory documents, and electronic health records. These applications facilitate more effective drug discovery, preclinical testing, clinical trials, pharmacovigilance, and regulatory compliance. Furthermore, NLP tools are helping researchers identify novel drug targets, optimize clinical trial designs, improve patient recruitment, and monitor post-market safety.(1).

Keywords

Introduction

Natural language processing (NLP) combines computational linguistics, machine learning, and deep learning models to process human language.

Computational linguistics: Computational linguistics is the science of understanding and constructing human language models with computers and software tools. Researchers use computational linguistics methods, such as syntactic and semantic analysis, to create frameworks that help machines understand conversational human language. Tools like language translators, text-to-speech synthesizers, and speech recognition software are based on computational linguistics. Machine learning: Machine learning is a technology that trains a computer with sample data to improve its efficiency. Human language has several features like sarcasm, metaphors, variations in sentence structure, plus grammar and usage exceptions that take humans years to learn. Programmers use machine learning methods to teach NLP applications to recognize and accurately understand these features from the start. Deep learning: Deep learning is a specific field of machine learning which teaches computers to learn and think like humans. It involves a neural network that consists of data processing nodes structured to resemble the human brain. With deep learning, computers recognize, classify, and co-relate complex patterns in the input data. NLP implementation steps: Typically, NLP implementation begins by gathering and preparing unstructured text or speech data from sources like cloud data warehouses, surveys, emails, or internal business process applications. Pre-processing: The NLP software uses pre-processing techniques such as tokenization, stemming, lemmatization, and stop word removal to prepare the data for various applications.  

Here's a description of these techniques:

Tokenization breaks a sentence into individual units of words or phrases.  Stemming and lemmatization simplify words into their root form. For example, these processes turn "starting" into "start."  Stop word removal ensures that words that do not add significant meaning to a sentence, such as "for" and "with," are removed.

Training: Researchers use the pre-processed data and machine learning to train NLP models to perform specific applications based on the provided textual information. Training NLP algorithms requires feeding the software with large data samples to increase the algorithms' accuracy.

Deployment and inference: Machine learning experts then deploy the model or integrate it into an existing production environment. The NLP model receives input and predicts an output for the specific use case the models designed for. You can run the NLP application on live data and obtain the required output. (2)

NLP In Clinical Trails:

Clinical trial texts involve valuable information for medical and clinical research, contributing to the solution of problems regarding the quality of healthcare and clinical decision support. However, usually, a significant portion of essential clinical trial information is documented and stored within unstructured texts, making it challenging to effectively and precisely extract useful information. Furthermore, it can be time-consuming and error-prone to convert such unstructured texts into structured ones, which may fail to capture multifarious information (5). Thus, the extraction of appropriate features from clinical narratives consists of unlocking the hidden knowledge, as well as enabling the conduction of advanced reasoning tasks, for example, diagnosis explanation, disease progression modeling, and treatment effectiveness analytics(6) . There are at least two types of motivations worthy of being highlighted for the conversion of unstructured texts into structured ones including reducing the time of manual screening and enhancing the reuse of such data to realize the automatic processing of large-scale texts.(7) The drug development process is lengthy, complex, and expensive, which is why it’s important for pharmaceutical companies to explore innovative technologies that can address bottlenecks and provide efficiencies. Clinical trials are one of the most expensive stages of drug development, and thus a key focal area for improvements. Improving clinical trial performance starts with selecting the right patient populations for inclusion. Additionally, effective mechanisms for identifying adverse events in near-real-time are important for minimizing disruptive patient safety events. These processes have become increasingly challenging as the amount of available health data proliferates. According to Dell EMC, healthcare organizations have seen a mind-boggling 878% growth rate for health data since 2016.

This surging amount of health data, coupled with its complexity, has made it nearly impossible for humans to properly analyze data before, during, and after clinical trials without leveraging technology. To efficiently develop new drugs, pharma companies must process, sort, and share data at speeds and volumes that exceeds human capacity. To help manage this avalanche of data, more pharmaceutical companies are turning to natural language processing (NLP) technology to mine unstructured, text-based documents and convert the data into structured information that can be analyzed by a computer. NLP can help pharmaceutical companies speed development and reduce costs. For example, in advance of clinical trial development, NLP can help to stratify patients, and during trials, NLP can quickly identify patient safety events. The following sections provide real-world examples of how two companies have leveraged NLP to accomplish these important objectives. (3)

Enhancing Data Extraction and Management

Clinical trials generate vast amounts of unstructured data from various sources, including patient records, clinical notes, and research papers. NLP can efficiently extract relevant information from these texts, transforming unstructured data into structured, usable formats. Automated Data Extraction: NLP algorithms can sift through large datasets, extracting critical information such as patient demographics, medical histories, and trial outcomes. Improved Data Quality: By standardizing data extraction processes, NLP reduces human error, ensuring higher accuracy and reliability of data.

Facilitating Patient Recruitment

Finding suitable participants for clinical trials is often a challenging and time-consuming process. NLP can streamline patient recruitment by analyzing medical records and identifying potential candidates who meet the trial’s inclusion criteria.

Precision Matching: NLP tools can match patient profiles with trial requirements more accurately than manual methods. Enhanced Outreach: NLP can help design targeted communication strategies to reach potential participants, increasing engagement and reducing recruitment time. Improving Patient Monitoring and Adverse Event Reporting: Continuous monitoring of trial participants is crucial for assessing treatment efficacy and safety. NLP can aid in real-time monitoring and reporting of adverse events. Real-Time Analysis: NLP systems can analyze patient feedback and clinical notes in real-time, identifying potential adverse events early. Automated Reporting: NLP can automate the reporting process, ensuring timely and accurate documentation of adverse events.

Applications of NLP in Clinical Trials

Literature Review and Synthesis: NLP can automate the process of reviewing and synthesizing scientific literature, saving researchers significant time and effort.

Automated Literature Search: NLP tools can scan thousands of research papers, identifying relevant studies and summarizing key findings.

Evidence Synthesis: NLP can help synthesize evidence from multiple studies, providing comprehensive insights and identifying research gaps. Protocol Development and Compliance: Developing and adhering to clinical trial protocols is essential for regulatory compliance and trial success. NLP can assist in protocol development and monitoring. Protocol Optimization: NLP can analyze existing protocols and suggest improvements based on historical data and current research.

Compliance Monitoring: NLP tools can monitor trial activities and documentation for protocol adherence, flagging potential compliance issues.

Enhancing Data Interpretation and Insights: NLP can transform raw data into meaningful insights, supporting decision-making processes in clinical trials. Trend Analysis: NLP in conjunction with other algorithms, including those from the fields of machine learning and deep learning, can identify trends and patterns in clinical data, helping researchers understand treatment effects and patient responses. Predictive Analytics: NLP can support predictive modeling, forecasting outcomes based on historical data and current findings. The Latest Trends in NLP-Enhanced Clinical Trials Research Several latest research achievements and outcomes in the field of the NLP-enhanced clinical trials. First, there was a trend toward drug side-effect signals. Cohort selection is an especially challenging task to which NLP and deep learning techniques can make a significant difference. For example, based on a collection of online posts from known statin users, Timimi et al. (8) adopted NLP techniques and hands-on linguistic analysis for the identification of drug side-effect signals. Experimental results indicated that statin users correlated statistically and significant. Challenges of Implementing NLP in Clinical Trials Data Privacy and Security: Handling sensitive patient data requires strict adherence to privacy regulations and robust security measures. Regulatory Compliance: Ensuring compliance with data protection regulations such as DPDPA is crucial. Data Anonymization: NLP systems must anonymize patient data to protect privacy while maintaining data utility. Handling Unstructured Data: Clinical data is often unstructured and varies in quality, posing challenges for NLP systems.

Data Standardization: Standardizing data formats and terminology is essential for effective NLP implementation.

Noise Reduction: NLP tools must be capable of filtering out irrelevant information and focusing on meaningful data.Algorithm Bias and Accuracy: NLP algorithms are only as good as the data they are trained on, and biases in training data can lead to skewed results.

Bias Mitigation: Continuous monitoring and updating of NLP models are necessary to minimize bias. Accuracy Improvement: Ensuring high accuracy in data extraction and interpretation is critical for reliable outcomes. Future Prospects of NLP in Clinical Trials: The future of NLP in clinical trials looks promising, with advancements in AI and machine learning paving the way for more sophisticated applications. Integration with AI: Combining NLP with other AI technologies can enhance its capabilities, enabling more comprehensive data analysis and insights. Personalized Medicine: NLP can support the development of personalized treatment plans by analyzing individual patient data and predicting responses to therapies. Global Collaboration: NLP can facilitate global collaboration in clinical research, allowing researchers to share and analyze data across borders.

NLP In Regulatory Affairs:

The pharmaceutical industry is one of the world’s most heavily regulated industries, and the traditional document-centric approach poses challenges in terms of efficiency, collaboration, and compliance. Regulatory frameworks, guidelines, and reporting requirements are continuously evolving, and it is crucial for drug developers to keep pace with these regulatory changes, to avoid compliance issues and concerns.

Regulatory affairs are often perceived as traditionally conservative, with a heavily manual workload requiring human input for many repetitive tasks during operations. Accessing and analyzing the key data needed from the vast amounts of documents to develop submissions, keep labels up to date, understand guidelines, and maintain compliance with constantly shifting regulations requires significant resources in the form of time, money, and effort – activities that add to pharmaceutical companies’ costs but do not necessarily enhance revenue. To overcome these barriers, drug developers are looking for digital transformations within regulatory disciplines to move from a document-driven to a data-driven approach. Regulatory teams need innovative technologies and systems that enable them to discover key data within regulatory documents, and extract and standardize these attributes, for use in downstream processes such as reporting, labeling, master data management, or structured content authoring.

NLP provides substantial value across several regulatory disciplines, including:

Regulatory labeling: Access to drug labels from some of the larger regulatory authorities is important to help labeling teams find reference information for disease and symptom terms, contraindications, adverse events, special populations, and more. Regulatory intelligence: Access to the landscape of regulatory updates, with integrated data flows to consume textual documents, both internal (such as corrective and preventive actions) and external (such as regulatory guidelines and FDA letters) is essential for regulatory teams. Regulatory mapping: Compliance teams need a means of finding key data attributes from unstructured text documents and mapping that data to standards, such as Identification of Medicinal Products (IDMP), a set of international standards that define the rules that uniquely identify medical products. Internal and external risk management: Top pharmaceutical company’s product development and supply team needed a way to improve its understanding of internal and external risk management data to optimize the formulations, commercial supply, and post[1]market regulatory compliance of its products. To fuel the initiative, the team developed a data lake to capture important internal and external feeds. Internal feeds included deviations, corrective and preventative actions (CAPAs), risks, and responses to questions (RTQs). External feeds included FDA warning letters, biological license applications (BLA) review reports, white papers, and industry benchmark repositories. The team employed NLP to structure and generate this intelligence data, extracting concepts, relationships, and sentiments embedded in the information. The data’s value to the team is further enhanced by easy-to-understand visualizations, enabling end-users to drill down and navigate the information. These data pipelines and workflows are updated automatically and deliver sustainable and scalable reporting of the regulatory landscape, featuring key risks and recommendations to act upon. Semi-automated regulatory intelligence tracking: Often, compliance teams depend on manual methods to monitor regulatory affairs, such as having individual team members regularly perform checks of relevant agency websites or subscribe to industry emails, to stay up-to-date on recent guidelines, public consultations, and meeting conclusions. Although the process is important because it provides compliance teams with essential intelligence to identify key concerns, deadlines, events, and regulatory decisions for compounds of interest, it is generally costly in terms of resources and time. One pharmaceutical company surmounted these barriers by using NLP to create a workflow to semi-automate information acquisition and summaries. A key feature of the company’s approach involved the integration of NLP technology with Large Language Models (LLMs), which served to enhance human teams’ abilities and drive more effective decision-making. With these tools, the company used a combination of AI and human capabilities to create a regulatory intelligence assistant, which provided team members with user-friendly question-and-answer access to updated regulatory information and risk categorization for substances of interest. By employing this model, the team delivers dynamic insights into various regulatory fields, highlighting major areas of risk, by extracting, summarizing, and classifying information for user-specified substances. Access to drug labels for more effective authoring: A leading pharmaceutical company is utilizing NLP technology to explore drug label data efficiently. Various teams within the company, including global labeling, regulatory affairs, medical, and safety, faced the challenge of identifying and accessing labels and label content from diverse sources and in multiple languages. To address this, a labeling intelligence “hub” was implemented, incorporating FDA Drug Labels, EMA Drug Labels, and local European databases, powered by NLP. The tool enables users to conduct customized searches, refine results, and export data for further analysis. Additionally, users can compare specific labels through an interactive view and access original documents directly. This solution streamlines the process of developing new labels, updating existing ones, and expediting regulatory approval, ultimately saving time for the teams involved. NLP for identification of medicinal products and regulatory master data management: IDMP (Identification of Medicinal Products) is a set of international standards, developed by the ISO, to define the rules that uniquely identify medicinal products and the relevant elements to identify them. IDMP is being adopted globally by health regulatory agencies and provides a common language to connect currently siloed data across R&D, safety and regulatory, and supply chain systems. Many pharma companies are using IDMP implementation to assist with master data management (MDM) across the enterprise. But one of the key challenges is that many of the data entities required are buried in unconnected silos of unstructured text. Constant changes in regulations mean that companies require new tools and solutions to assist with regulatory review and compliance, to respond in an effective and timely manner. In some cases, meeting the regulators’ requirements is straightforward, while in other cases, accessing the necessary data can take a significant amount of time, money, and effort, while not necessarily increasing revenue. The inefficient, laborious, and error-prone nature of traditional manual search processes has led many pharmaceutical companies to use AI-based technologies to provide relief to compliance teams. Due to its ability to transform a wealth of internal and external data into high-value, actionable insights, NLP is among the primary AI-based technologies pharmaceutical companies are using to synthesize information from many sources to deliver critical supporting evidence for business decisions. Utilizing AI/ML tools, such as Natural Language Processing, enables digital transformation to improve efficiencies in regulatory disciplines. These innovative tools bring agility to regulatory teams, enabling them to rapidly address critical business issues across regulatory affairs.

NLP In Health:

Factors Behind NLP In Healthcare System: NLP, a part of AI, goes for fundamentally decreasing the separation between the abilities of a human and a machine. As it getting increasingly more footing in the medicinal services space, providers are concentrating on creating arrangements that can comprehend, break down, and produce languages would humans be able to can get it.: • Handle the Surge in Clinical Data The expanded utilization of patient health record frameworks and the advanced change of medication has prompted a spike in the volume of information accessible with health care associations. The need to bode well out of this information and attract trustworthy bits of knowledge happens to be a noteworthy driver.

 • Support Value-Based Care and Population Health Management The move in plans of action and result desires is driving the requirement for better utilization of unstructured information. Conventional health data frameworks have been concentrating on getting an incentive from the 20 percent of medicinal services information that comes in organized organizations through clinical channels. For cutting edge understanding health record frameworks, oversaw care, PHM applications, and investigation and revealing, there is a pressing need to take advantage of the supply of unstructured data that is just getting heaped up with medicinal services associations. NLP in Healthcare could understand these difficulties through various use cases.(10)  Improving Clinical Documentation Electronic Health Record arrangements regularly have an intricate structure, so that archiving information in them is an issue. With discourse to-content transcription, information can be consequently caught at the purpose of consideration, opening up doctors from the monotonous undertaking of reporting care conveyance. Making CAC progressively Efficient Computer-helped coding can be improved from multiple points of view with NLP. CAC extricates data about strategies to catch codes and expand claims. This can genuinely help HCOs make the move from charge for-administration to a worth based model, along these lines improving the patient experience funda mentally. (11) Improve Patient-Provider Interactions: with patients these days need full focus from their human services providers. This leaves specialists feeling overpowered and wore out as they bring to the table customized administrations while likewise overseeing troublesome documentation including charging administrations. Studies have demonstrated how a greater part of consideration experts experience burnout at their working environments. Coordinating NLP with electronic health record frameworks will help take off remaining burden from specialists and make investigation simpler. Effectively, remote helpers, for example, Siri, Cortana, and Alexa have made it into human services associations, filling in as authoritative guides, assisting with client administration errands and help work area obligations. Before long, NLP in Healthcare may make menial helpers traverse to the clinical side of the health care industry as requesting partners or medicinal copyists. Empower Patients with Health Literacy With conversational AI previously being a triumph inside the human services space, a key use-case and advantage of executing this innovation is the capacity to enable patients to comprehend their indications and increase more learning about their conditions. By ending up progressively mindful of their health conditions, patients can settle on educated choices, and keep their health on track by interfacing with a clever chatbot (9). In a recent report, scientists utilized NLP answers for match clinical terms from their archives with their layman language partners. Thusly, they expected to improve persistent EHR understanding and the patient entryway experience. Common Language Processing in human services could help patients' comprehension of EHR entryways, opening up chances to make them increasingly mindful of their health.  Address the Need for Higher Quality of Healthcare NLP can be the leader in evaluating and improving the nature of medicinal services by estimating doctor execution and distinguishing holes in consideration conveyance. Research has demonstrated that man-made consciousness in health care can facilitate the procedure of doctor evaluation and robotize tolerant finding, lessening the time and human exertion required in completing routine undertakings, for example, quiet conclusion. NLP in health care can likewise.

Electronic Health Records (EHRs), which are automated compilations of health care activities and assessments, are increasingly prevalent and essential for healthcare provision, administration, and research (1). The data found in EHRs can be both structured and unstructured (2) Structured EHR data comprises heterogeneous sources in fixed numerical or categorical areas, such as diagnoses, prescriptions, and laboratory values. On the other hand, produced by healthcare personnel, clinical documentation or note and discharge summaries represent instances of unstructured data. Clinical documentation or notes are input as free text into EHRs, offering a complete picture of the patient’s condition. The adoption of EHRs has increased rapidly around the world. In the United States, it has increased dramatically from 10% to nearly 96% in just 10 years (2008–2017). In China, this increase is slightly more than 85%. A similar trend has been observed in General Practices, large hospitals, and health services in Australia. The Emergence of AI and NLP in Healthcare- Our world has witnessed an exponential surge in healthcare data, driven by Electronic Health Records (EHRs), wearable devices, and the digitization of medical information. With this data deluge comes an unprecedented opportunity to harness AI and NLP technologies. These technologies are more than buzzwords; they are the result of decades of research, development, and the convergence of computational power and medical knowledge. AI in healthcare is no longer a distant dream but a tangible reality. From diagnosing diseases to predicting patient outcomes, AI is making its mark across the healthcare spectrum. NLP, a subfield of AI, focuses on the interaction between computers and human languages, offering the promise of bridging the communication gap in healthcare.

Diagnosis and Treatment (12,13,14)

Support In the rapidly evolving landscape of healthcare, the integration of Artificial Intelligence (AI) and NLP is not confined to administrative tasks alone. It extends its transformative touch into the realm of diagnosis and treatment support, enhancing healthcare professionals' capabilities and ultimately benefiting patients.

AI-NLP in Symptom Assessment and Differential Diagnosis:

Symptom assessment and diagnosis is the cornerstone of effective healthcare. AI-NLP technologies, backed by vast medical knowledge and sophisticated algorithms, are redefining how these processes unfold. Healthcare professionals can now leverage AI-NLP-powered systems to assist in the evaluation of patient symptoms. These systems process a patient's description of symptoms, medical history, and other relevant information, comparing it to an extensive database of medical knowledge. Through this analysis, they can provide healthcare providers with a list of potential diagnoses and insights into differential diagnosis. This capability augments the diagnostic process by offering healthcare professionals valuable decision support. It helps in identifying rare or easily overlooked conditions, reducing the risk of misdiagnosis, and facilitating early intervention.

Patient Privacy and Data Security:

Patient data lies at the heart of healthcare, and safeguarding its privacy and security is an ethical imperative. AI-NLP systems have the capacity to process and store vast amounts of sensitive patient information, making data protection a paramount concern. This ethical dimension underscores the responsibility of healthcare organizations and technology providers to implement stringent data security measures. Encryption, anonymization, and robust storage practices must be in place to shield patient data from unauthorized access and breaches. Moreover, ensuring that patients have full transparency regarding the use of their data and providing mechanisms for informed consent are essential components of ethical data handling in AI-driven healthcare communication. Balancing the potential for improved healthcare outcomes with the imperative of patient data security represents a multifaceted ethical challenge that demands our vigilant stewardship. (15,16,17) NLP will play a significant role in accelerating the decision-making process in the healthcare area. However, the real rewards of developing good algorithms will depend heavily on the quality of the data that they acquire and maintain. The faster decision-making process will allow physicians to focus on the value-added care of patients. NLP with Deep Learning and Computer Vision can process a variety of data together to take precise decisions. Collaborative research can lead to a higher level of treatment in Healthcare. Considering the impact of AI techniques, these systems need to be designed and built very carefully in a larger socio-ecological context of clinical care settings to provide better healthcare to society (19)

NLP In Drug Discovery:

Drug discovery and development pipelines are long, complex and depend on numerous factors. Machine learning (ML) approaches provide a set of tools that can improve discovery and decision making for well-specified questions with abundant, high-quality data. Opportunities to apply ML occur in all stages of drug discovery. Examples include target validation, identification of prognostic biomarkers and analysis of digital pathology data in clinical trials. Applications have ranged in context and methodology, with some approaches yielding accurate predictions and insights (20). NLP is playing a critical role in accelerating small molecule drug discovery. Prior knowledge on the manufacturability or contraindications of a drug can be extracted from academic publications and proprietary data sets. NLP can also help with clinical trial analysis and accelerate the process of taking a drug to market.

Transformer architectures are popular in NLP, but these tools can also be used to understand the language of chemistry and biology. For example, text-based representations of chemical structure such as SMILES (Simplified Input Molecular Line Entry System) can be understood by transformer-based architectures leading to incredible capabilities for drug property evaluation and generative chemistry.  Large transformer model developed by AstraZeneca and NVIDIA, is used for a wide range of tasks, including reaction prediction, molecular optimization, and de novo molecule generation. Transformer-based NLP models are instrumental in understanding and predicting the structure and function of biomolecules like proteins. Much like they do for natural language, transformer-based representations of protein sequences provide powerful embeddings for use in downstream AI tasks, like predicting the final folded state of a protein, understanding the strength of protein-protein or protein-small molecule interactions, or in the design of protein structure provided a biological target. Artificial Intelligence-powered technologies like NLP are becoming critical to the pharmaceutical and life sciences industries as they become overwhelmed with volumes of data, almost 80 per cent of which exists as inaccessible and unusable unstructured text. The availability of domain-driven, easy-to-use NLP technologies plays a central role in enabling businesses to mobilize unstructured data at scale and to embrace a truly data-driven approach to insight generation and innovation.    NLP solutions are now being used at all stages of drug discovery, from analyzing clinical trial digital pathology data to identifying predictive biomarkers. These technologies have been proven to significantly reduce cost and cycle times, enhance the scope and accuracy of analysis and provide new insights that accelerate the development of new drugs. However, NLP in drug discovery is not a monolithic concept. There are several possible approaches, each of which may be particularly suited for specific applications. Moreover, any comprehensive solution for integrated enterprise-wide analysis will likely require a blended or hybrid NLP approach. So here‘s a quick dive into some of the key approaches to NLP in drug discovery.       

Key NLP Approaches

NLP consists of two main phases, data preprocessing and algorithm development. NLP algorithms can be classified under three main types, rules-based, ML-based and Hybrid approaches.

Rules-Based NLP

These systems depend on carefully curated sets of linguistic rules designed by experts to classify content into relevant categories. This approach emerged during the early days of NLP development and is still in use today. However, a rules-based approach requires a lot of manual input and is best suited for linguistic tasks where the rule base is readily available and/or manageably small. It becomes practically impossible to manually generate and maintain rules for complex environments.

ML-Based NLP

ML-based algorithms use statistical methods to learn from large training datasets. These algorithms learn from pre-labeled examples to understand the relationships between different parts of texts and make the connections between specific inputs and required outputs.

Based on their approach to learning, ML-based methods can be further classified under supervised, unsupervised and self-supervised NLP.   

Supervised NLP

Supervised NLP models are trained using well-labeled, or tagged, data. These models learn to map the function between known data inputs and outputs and then use this to predict the best output that corresponds to new incoming data. Supervised NLP works best with large volumes of readily available labelled data. However, building, deploying, and maintaining these models require a lot of time and technical expertise.

Unsupervised NLP

This is a more advanced and computationally complex approach to analyzing, clustering and discovering patterns in unlabeled data without the need for any manual intervention. Unsupervised NLP enables the extraction of value from the predominance of unlabeled text and can be especially important for common NLP tasks like PoS tagging or syntactic parsing. However, unsupervised NLP methods cannot be used for tasks like classification without substantial retraining with annotated data.

Self-Supervised Nlp

Self-supervised learning is still a relatively new concept that has had a significant impact on NLP. In this technique, part of an input dataset is concealed and self-supervised learning algorithms then analyse the visible part to create the rules that will enable them to predict the hidden data. This process, also known as predictive or pretext learning, auto-generates the labels required for the system to learn thereby converting an unsupervised problem into a supervised problem. A key distinction between unsupervised and self-supervised learning is that in the former the focus is on the model rather than on the data while in the latter it is the other way around. In recent times, ML-based approaches have evolved into the NLP deep learning age driven by the explosion in digital text, increased processing power in the form of GPUs and TPUs and improved activation functions for neural networks. As a result, deep learning (DL) has become the dominant approach for a variety of NLP tasks. Today, there is a lot of focus on developing DL techniques for NLP tasks that are best expressed with a graph structure. One of the biggest breakthroughs in NLP in recent times has been the transformer, a deep learning model that leverages attention mechanisms to reinvent textual analytics. DL may not be the most efficient or effective solution for simple NLP tasks but it produced some groundbreaking results in named entity recognition, document classification and sentiment analysis.

Hybrid NLP

With hybrid NLP, the focus is on combining the best of rule- and ML-based approaches without having to compromise between the advantages and drawbacks of each. A hybrid system could integrate a machine-learning root classifier with a rules-based system with rules added to the latter for tags that have been incorrectly modeled by the former. Techniques like self-supervised learning can help reduce the human effort required for building models which in turn can be channeled into creating more scalable and accurate solutions. Combining top-down, symbolic, structured knowledge-based approaches with bottom-up, data-driven neural models will enable organizations to optimize resource usage, increase the flexibility of their models and accelerate time to insight.

REFERENCES

1. What is NLP? - Natural Language Processing Explained - AWSWhat is NLP? - Natural Language Processing Explained - AWSWhat is NLP? - Natural Language Processing Explained - AWS
2. What is NLP? - Natural Language Processing Explained - AWS.html
3. Using Natural Language Processing to Improve Clinical Trial Design and Patient Safety Performance - ACRP
4. The Role of Natural Language Processing (NLP) in Clinical Trials - dphsindia.com
5. Jung, H.; Hong, S.; Park, J.; Park, M.; Sun, J.; Lee, S.; Ahn, J.; Ahn, M.; Park, K. MA19. 06 Successful Development of Realtime Automatically Updated Data Warehouse in Health Care (ROOT-S). J. Thorac. Oncol. 2019, 14, S328.
6. Jonnalagadda, S.; Cohen, T.; Wu, S.; Gonzalez, G. Enhancing clinical concept extraction with distributional semantics. J. Biomed. Inform. 2012, 45, 129–140.
7. Kreimeyer, K.; Foster, M.; Pandey, A.; Arya, N.; Halford, G.; Jones, S.F.; Forshee, R.; Walderhaug, M.; Botsis, T. Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review. J. Biomed. Inform. 2017, 73, 14–29.
8. Segura-Bedmar, I.; Raez, P. Cohort selection for clinical trials using deep learning models. J. Am. Med. Inform. Assoc. 2019, 26, 1181–1188. Timimi, F.; Ray, S.; Jones, E.; Aase, L.; Hoffman, K. Patient-Reported Outcomes in Online Communications on Statins, Memory, and Cognition: Qualitative Analysis Using Online Communities. J. Med. Internet Res. 2019, 21, e14809.
9. Hassan A, Ali MDI, Ahammed R, Bourouis S, Khan MM. Development of NLP-integrated intelligent web system for E-mental health. Comput Math Methods Med. 2021; 2021: 1546343. doi: 10.1155/2021/1546343, PMID 34938348.
10. Khadija A, Zahra FF, Naceur A. AI-powered health chatbots: toward a general architecture. Procedia Comput Sci. 2021; 191: 355-60. doi: 10.1016/j.procs.2021.07 .048.
11. Sapci AH, Sapci HA. Artificial intelligence education and tools for medical and health informatics students: systematic review. JMIR Med Educ. 2020; 6(1): e19285. doi: 10. 2196/19285, PMID 32602844. 
12. Straw I, Callison-Burch C. Artificial Intelligence in mental health and the biases of language-based models. PLOS ONE. 2020; 15(12): e0240376. doi: 10.1371/journal.po ne.0240376, PMID 33332380
13. Yang LWY, Ng WY, Lei X, Tan SCY, Wang Z, Yan M, et al. Development and testing of a multi-lingual Natural Language Processing-based deep learning system in 10 languages for COVID-19 pandemic crisis: A multi-center study. Front Public Health. 2023; 11: 1063466. doi: 10.3389/fpubh.2023.1063466, PMID 36860378.
14. Hudaa S, Setiyadi DB, Lydia EL, Shankar K, Nguyen PT, Hashim W, Maseleno A. Natural language processing utilization in healthcare. International Journal of Engineering and Advanced Technology. 2019 Aug;8(6):1117-20.
15. WaringJ. et al,Automated machine learning: Review of the state-of-the-art and opportunities for healthcareArtif. Intell. Med.(2020)
16. AfzalN. et al.Natural language processing of clinical notes for identification of critical limb ischemiaInt. J. Med. Inform.(2018)
17. JuhnY. et al.Artificial intelligence approaches using natural language processing to advance EHR-based clinical researchJ. Allergy Clin. Immunol.
18. Jain K, Prajapati V. NLP/deep learning techniques in healthcare for decision making. Primary Health Care: Open Access. 2021 Mar 30;11(3):373-80.
19. Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P, Spitzer M, Zhao S. Applications of machine learning in drug discovery and development. Nature reviews Drug discovery. 2019 Jun;18(6):463-77